CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances
In the last decade, Chimeric Antigen Receptor (CAR)-T cell therapy has emerged as a
promising immunotherapeutic approach to fight cancers. This approach consists of …
promising immunotherapeutic approach to fight cancers. This approach consists of …
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Y Zhang, W Zhou, J Yang, J Yang, W Wang - Experimental Hematology & …, 2023 - Springer
Natural killer (NK) cells, a unique component of the innate immune system, are inherent
killers of stressed and transformed cells. Based on their potent capacity to kill cancer cells …
killers of stressed and transformed cells. Based on their potent capacity to kill cancer cells …
Low-dose non-targeted effects and mitochondrial control
D Averbeck - International Journal of Molecular Sciences, 2023 - mdpi.com
Non-targeted effects (NTE) have been generally regarded as a low-dose ionizing radiation
(IR) phenomenon. Recently, regarding long distant abscopal effects have also been …
(IR) phenomenon. Recently, regarding long distant abscopal effects have also been …
Soluble programmed death ligand‐1‐induced immunosuppressive effects on chimeric antigen receptor‐natural killer cells targeting Glypican‐3 in hepatocellular …
Although the pre‐clinical study of chimeric antigen receptor (CAR)‐natural killer (NK) cell
was effective against various tumours, immunosuppression mediated by tumour …
was effective against various tumours, immunosuppression mediated by tumour …
[HTML][HTML] Establishment of an efficient ex vivo expansion strategy for human natural killer cells stimulated by defined cytokine cocktail and antibodies against natural …
T Nakazawa, T Morimoto, R Maeoka, R Matsuda… - Regenerative …, 2022 - Elsevier
Introduction Cell-based immunotherapy is categorized as a regenerative therapy under the
Regenerative Medicine Safety Act in Japan. Natural killer (NK) cell-based immunotherapy is …
Regenerative Medicine Safety Act in Japan. Natural killer (NK) cell-based immunotherapy is …
Evolving tumor characteristics and smart nanodrugs for tumor immunotherapy
W Sun, S Xie, SF Liu, X Hu, D Xing - International Journal of …, 2024 - Taylor & Francis
Typical physiological characteristics of tumors, such as weak acidity, low oxygen content,
and upregulation of certain enzymes in the tumor microenvironment (TME), provide survival …
and upregulation of certain enzymes in the tumor microenvironment (TME), provide survival …
Opportunities and challenges of natural killer cell-derived extracellular vesicles
Y Qi, X Zhao, Y Dong, M Wang, J Wang… - … in Bioengineering and …, 2023 - frontiersin.org
Extracellular vesicles (EVs) are increasingly recognized as important intermediaries of
intercellular communication. They have significant roles in many physiological and …
intercellular communication. They have significant roles in many physiological and …
An observational study on chronic pain biomarkers in fibromyalgia and osteoarthritis patients: which role for mu opioid receptor's expression on NK cells?
The evaluation of chronic pain is challenging because of the lack of specific biomarkers. We
identified the Mu opioid receptor-positive (Mu+) B cell percentage of expression, named Mu …
identified the Mu opioid receptor-positive (Mu+) B cell percentage of expression, named Mu …
'Off the shelf'immunotherapies: Generation and application of pluripotent stem cell‐derived immune cells
C Wang, J Liu, W Li - Cell Proliferation, 2023 - Wiley Online Library
In recent years, great strides have been made toward the development of immune cell‐
based therapies in the treatment of refractory malignancies. Primary T cells and NK cells …
based therapies in the treatment of refractory malignancies. Primary T cells and NK cells …
Anticancer traits of chimeric antigen receptors (CARs)-Natural Killer (NK) cells as novel approaches for melanoma treatment
M Bahmanyar, MK Vakil, GRL Al-Awsi, SA Kouhpayeh… - BMC cancer, 2022 - Springer
Owing to non-responsiveness of a high number of patients to the common melanoma
therapies, seeking novel approaches seem as an unmet requirement. Chimeric antigen …
therapies, seeking novel approaches seem as an unmet requirement. Chimeric antigen …